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Introduction
Rheumatoid arthritis (RA) is an autoimmune disease with unknown etiology, which affects about 2% of the population. Although arthritis rarely kills, chronic RA is associated with lower life expectancy and a dramatically impaired quality of life. At present RA is incurable, consequently joint replacement surgery becomes the final recourse for many patients. The disease can last for decades, if not a lifetime, and the ideal treatment should have a matching chronicity of effect. For this reason and because of delivery problems of conventional drugs to the joint space, the gene therapeutic approach is being considered for treatment of RA. 1785-1793. adenoviral transduction of the synovium. Goossens et al 7 have shown that infection efficiency in human synovial cells can be enhanced by substitution of the type 5 fiber with the type 16 fiber, which does not use CAR for cell binding. Recently, Dmitriev et al 8 have shown that introduction of the RGD motif in the HI loop of the fiber knob resulted in a CAR-independent cell entry via interaction with RGD binding integrins. 8 RGD binding integrins are highly expressed on synovium, [9] [10] [11] [12] [13] and could be better suited as receptors for adenoviral entry in synovial cells than the CAR. The only downside is that insertion of the RGD sequence for adenoviral entry will result in a broad tropism of the adenovirus. This is not a problem for transfection of the lining cells in the joint, as targeted infection of the synovial lining can be accomplished by the intra-articular injection of the virus. In this study, we explored the transduction efficiency of a RGD-modified AdV in normal and arthritic murine knee joints, and determined the therapeutic effect of IL-1Ra gene transfer in the murine CIA model. CIA is a polyarthritis, which can be inhibited by high systemic doses of IL-1Ra 14, 15 or by local production of IL1Ra with the ex vivo approach. 16 The CIA model is highly IL-1-dependent, 14, 17 whereas TNF␣ seems to be important only at the onset of collagen arthritis. 14 High systemic doses of IL-1Ra are necessary to block CIA; a continuous supply of 1 mg/day is needed for optimal suppression. 14 Transduction of the synovial lining cells in normal knee joints was up to 38 times more efficient when the RGD-mediated pathway was used, and infection in an active arthritis was five to 69 times more efficient, dependent on the type of inflammation. More importantly, using the RGD-modified AdV for transduction of the synovial lining with the mIL-1Ra transgene markedly improved the inhibition of CIA as compared with the conventional virus in both a prophylactic and therapeutic protocol.
units (ffu) virus, luciferase (luc) activity in Ad5LucRGD-injected joints was up to 38 times higher than in AdCMVLucinjected joints, and in arthritic joints the transduction efficiency was up to 69 times higher for the Ad5LucRGD viruses. Transduction of the synovial lining by the RGDmodified adenovirus containing the mIL-1Ra transgene, markedly improved the inhibition of CIA compared with the conventional virus in both a prophylactic and therapeutic treatment protocol. These results show that targeting integrins with the RGD-modified AdV improved the outcome of gene therapy for arthritis. Gene Therapy (2001)
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Results

In vitro transduction of synoviocytes
The ␣ v subunit is the most frequently used subunit in RGD binding integrins. 18 We have determined the relative content of both the ␣ v subunit and the mCAR receptor in murine fibroblasts by semi-quantitative RT-PCR. RNA was extracted from cells isolated from a cell line that originated from the synovium of C57/BL6 mice (obtained from Dr Van Lent, our laboratory). The ␣ v receptor was detected 10 PCR cycles before the mCAR (corrected by the GAPDH signal) (Figure 1a ). To determine the consequence of the difference in mRNA content we transduced synovial cells in vitro with the conventional AdCMVLuc or the RGD-modified Ad5LucRGD AdV. These vectors are isogenic except for the added RGD sequence, and carry the luciferase gene (Luc) driven by the CMV promoter. One day after transduction luciferase production was measured in cell extracts (Figure 1b) . Luciferase production was 150 times higher in the RGD adenovirus-infected cells compared with the cells infected with conventional virus. These in vitro data show that bypassing the CAR receptor by use of the ␣ v integrin is a more efficient way for adenoviral transduction of synoviocytes, presumably because RGD-binding integrins are more abundantly present in those cells than CAR. 
In vivo transduction of normal murine knee joints
We have determined the mRNA content for the mCAR and ␣ v integrins in the synovium of C57/Bl6 mice. RNA was isolated from synovial biopsies of normal and arthritic murine and RT-PCR was performed for mCAR and ␣ v (Figure 2a) . The difference in mRNA content of these proteins was even larger than in the isolated synovial fibroblasts, mCAR was detectable at cycle 40 of the PCR, and the ␣ v integrin was already detectable at cycle 25. This shows that the amount of mCAR receptor in synoviocytes might be dramatically lower than the amount of RGD-binding integrins. The transduction efficiency of the RGD-modified adenovirus was measured in vivo. C57/Bl6 mice were intra-articularly injected with 10 5 , 10 6 or 10 7 ffu of the conventional AdCMVLuc or the RGD-modified Ad5lucRGD vector. One day later luciferase production was measured in the knee joints (Figure 2b ). Intra-articular luciferase activity was 17 to 38 times higher in the RGD-infected knee joints compared with the conventional infected knee joints, this confirms the in vitro data (Figure 1b) . These results show that the RGD-modified AdV has a much higher transduction efficiency of the synovium and could be more suitable for gene therapy of arthritic diseases.
Expression in inflammatory knee joints
Next, we studied the transduction efficiency of the RGDmodified AdV in an inflamed joint. Luciferase expression in the knee joint was measured 1 day after injection of the viruses. We have investigated the transduction efficiency in an irritant-induced acute arthritis (streptococcus cell wall (SCW) model), which is charac- terized by the abundant presence of inflammatory cells in the joint cavity (Figure 3a) . The transduction efficiency was markedly reduced for both the conventional and RGD-modified AdV. However, the transduction efficiency of the RGD adenoviruses was still five times higher than the conventional viruses. The transduction efficiency in a chronic arthritis, 4 weeks after an irritantinduced chronic synovitis (zymosan-induced arthritis) without inflammatory cells in the synovial cavity, was as high as in normal knee joints for the RGD-modified AdV. In contrast, the transduction efficiency of the conventional AdV was five times lower ( Figure 3a) . We have used an immunological arthritis model to exclude that this was dependent on the type of joint inflammation. In the antigen-induced arthritis (AIA) model, we obtained similar effects as in the irritant-induced arthritis model, both in the acute as well as in the chronic phase. The reduced transduction efficiency with the conventional AdV in both acute and chronic arthritis could not be explained by a reduction of the mCAR (mRNA) expression compared with the normal joint. We have found that the mCAR expression was 10 cycles up-regulated compared with the normal knee joints, while the ␣ v mRNA expression was the same in the arthritic knee joints as in the normal knee joints (Figure 3b ). The upregulation of the mCAR was seen in all arthritic models. In Figure 3a , the data of the 2-day flare up of the 3-week primary AIA are shown.
We have determined the localization of the transduced cells in the synovium during a chronic arthritis by intraarticular injection of Ad5GFPRGD or control Ad5GFP viruses. One day after injection, the GFP expression in These results show that the RGD-modified AdV transduces inflamed synovium with improved efficiency compared with the conventional viruses in both the acute and chronic phase of arthritis. Next, we studied the therapeutic significance of the higher transduction efficiency with RGD-modified AdV by using it for overexpression of mIL-1Ra in the murine CIA model.
Inhibition of CIA by RGD-mediated overexpression of mIL-1Ra
DBA/1 mice were immunized with bovine type II collagen on day 0 and given a booster on day 22. On day 24, CIA-negative mice were selected, and 10 7 ffu AdCMVLuc, Ad5LucRGD, Ad5mIL-1Ra, or Ad5mIL-1RaRGD were bilaterally injected into the knee joints (n = 10 mice). We measured luciferase activity in the AdCMVLuc and Ad5LucRGD control groups to obtain an accurate prediction of differences in transgene expression between the two groups during the CIA experiment (Figure 5a ). One day after transduction, the luciferase production in the RGD-modified AdV-transduced knee joints was 33 times higher than in the knee joints transduced by the conventional virus. Figure 5b shows the average clinical scores for the individual ipsilateral paws during the 2-week experiment. Overexpression of IL-1Ra in the knee joints had a distal inhibitory effect on the CIA activity. The Ad5mIL-1Ra group was not significantly different compared with the AdCMVLuc group, but the Ad5mIL-1RaRGD group has significantly ameliorated arthritis compared with the AdLucRGD group on days 31 and 38. More importantly, arthritis in the AdmIL-1RaRGD group was significantly inhibited in the paws compared with the AdmIL-1Ra group from day 31 onward. On day 38, knee joints were dissected, and processed for histology. The amount of inflammation, glycosaminoglycan (GAG) depletion of non-calcified cartilage, bone resorption and cartilage degradation was scored on a scale from 0 to 3 ( Figure 5c ). The histological scores of the Ad5mIL-1RaRGD group were significantly less for all parameters compared with the Ad5LucRGD group. Comparison of the RGD-modified virus to the conventional virus has shown a significant improvement in the prevention of GAG depletion in the non-calcified cartilage layer and prevention of bone resorption. Cartilage degradation was the only parameter significantly improved in the conventional Ad5mIL-1Ra virus group as compared with the AdCMVLuc control.
For clinical application it is important that an established disease can be effectively treated. We have designed a CIA experiment to attain two goals. First, we wanted to show therapeutic effect of the intra-articular mIL-1Ra overexpression after onset of CIA. Second, we wanted to show that injection of a smaller amount of the RGD-modified AdV could be as effective in suppression of CIA as a higher amount of the unmodified AdV. 10 5 ffu of the RGD-modified AdV resulted in comparable expression levels as 10 7 ffu of the unmodified AdV (Figure 2b ). DBA/1 mice were immunized with bovine type II collagen on day 0 and given a booster on day 22. On day 25, mice with at least one CIA-positive paw were selected. On day 25 and 27, mice were intra-articularly injected with 10 7 ffu Ad5mIL-1Ra, 10 5 ffu Ad5mIL-1RaRGD, or 10 7 ffu of the control vector Ad5LucRGD. We found that transduction of the synovial lining with 10 5 ffu of the AdmIL-1RaRGD vector effectively inhibited CIA almost as well as in the mice transduced with 10 7 ffu of the unmodified AdmIL-1Ra vector ( Figure 6 ). Importantly, the therapeutic effect on CIA seemed to be correlated to the amount of mIL-1Ra produced in the knee joints (Figure 6 ). IL-1Ra production in the control group transduced with 10 7 ffu of Ad5LucRGD was 1103 ± 151 pg/ml, and 7 days after injection the macroscopic score in the hind paws was 1.32 ± 0.15. Il-1Ra production in the group transduced with 10 7 ffu of the unmodified Ad5mIL-1Ra vector was 3690 ± 337 pg/ml, and 7 days later the macroscopic score was 0.5 ± 0.5. IL-1Ra production in the group transduced with 10 5 ffu of the RGDmodified Ad5mIL-1RaRGD vector was 3030 ± 347 pg/ml, and 7 days later the macroscopic score was 0.81 ± 0.64. These results show that the higher intra-articular transduction efficiency achieved with the RGD modification of the AdV is of clinical significance in the treatment of experimental arthritis.
Discussion
One of the factors that determine the transduction efficiency of the synovial lining in vivo, will be the amount of receptor available for viral entry. In primary ␣ v integrin-positive cells, the CAR receptor is rate limiting for infection by AdV. 6 We measured the mRNA content of the mCAR in murine synovial cells and have found that it was just detectable by RT-PCR. This suggests that changing the tropism of the virus could enhance the transduction efficiency of the synovium. Candidate receptors should be abundantly present in the synovial lining cells. RGD-binding integrins are highly expressed in the normal synovium. 9, 10, 12, 13, 19 We further evaluated the potential of the RGD-modified adenoviruses for transduction of the synovium by measuring the mRNA level for ␣ v in synovial cells. The ␣ v subunit was used as this subunit is most frequently present in RGD binding integrins. 18 We found that mRNA of the ␣ v integrin was more highly expressed in synovium than mRNA of the mCAR receptor. Bypassing the CAR receptor by adding the RGD sequence to the fiber knobs could greatly enhance the transduction efficiency in the synovial lining. Indeed, transduction of the synovial lining with the RGD-modified AdV has resulted in up to 38 times improvement of the transduction efficiency.
The increased transgene production at higher amounts of intra-articularly injected ffu of the conventional AdV (Figure 2) suggests that the CAR receptor is not the limiting factor. Hidaka et al 6 have shown that AdV transduction of CAR-deficient primary fibroblasts is possible with much lower efficiency at low MOI, but transduction efficiency is only four times lower than in CAR-sufficient fibroblasts at high MOI. As the transduction could not be inhibited by soluble fiber, the RGD sequence on the penton base, which is normally used for cell entry, [3] [4] [5] could be sufficient to permit gene transfer to CAR deficient cells. 6 Intra-articular transfer of the transgene to synoviocytes by the conventional AdV could be achieved partly by the low amounts of CAR receptor and partly by the penton-integrin interaction. Addition of the RGD sequence to the H1 loop of the fiber could further enhance the transfer of the transgene because of the better availability of the RGD-binding integrins and because the added cyclic RGD sequence has a higher affinity than the RGD sequence on the penton base. Furthermore, when the two receptor systems on the fiber and the penton work together, gene transfer is more effective. 6 Modification of the tropism of the adenovirus with the RGD sequence has additional beneficial effects besides improvement of the transduction efficiency. One of the beneficial effects is that the addition of the RGD sequence will avoid neutralization by serum antibodies against adenovirus serotype 5 in patients. 20 This is important as around 80% of the population have neutralizing antibodies against adenovirus type 5 in their serum. [20] [21] [22] We determined the clinical effectiveness of the optimization by comparison of the RGD AdV to the conventional AdV in their ability to modulate the CIA model when used for intra-articular mIL-1Ra overexpression. CIA could not be prevented when the conventional AdV was used for overexpression of IL-1Ra in the murine knee Gene Therapy joint ( Figure 5 ). The severity of the arthritis was just below the control AdCMVLuc-injected group, while in earlier experiments we saw that the CIA model can be totally blocked by high systemic amounts of IL-1Ra, even when started at a later time-point. 23 This suggests that the amount of locally produced IL-1Ra was either too low to block all of the IL-1 or the systemic role of IL-1 is important in CIA. In a subsequent experiment where mice were treated after onset of CIA (Figure 6 ), we injected the conventional virus twice. This resulted in a significant amelioration of the CIA at day 32. The higher transduction efficiency of the RGD-modified viruses has resulted in a significant reduction of the CIA compared with both the AdCMVLuc and the Ad5mIL-1Ra groups ( Figure 5 ). In Figure 6 we show that the inhibition of CIA by mIL-1Ra is correlated with the intra-articularly produced amount of mIL-1Ra.
The expression of RGD binding integrins is modulated in RA, for instance the ␣ v receptor is down-regulated, 10, 11, 13 and the ␣ 5 integrin is up-regulated. 19 The significance of the modulation for the RGD adenoviral trans- duction efficiency is not clear. Especially as Reynolds et al 24 have shown that the transgene expression profile can not be correlated with the expression for a particular integrin. We examined the effect of arthritis on the transduction efficiency in murine arthritis models. As in the normal joints, there was a remarkable difference between the transduction efficiency of the conventional and the RGDmodified adenovirus. In chronic arthritic knee joints, the transduction efficiency of the RGD-modified adenoviruses was only slightly less than in normal knee joints, in contrast to the conventional viruses. Surprisingly, we saw that on the mRNA level the CAR was up-regulated, while the mRNA level of the ␣ v integrins stayed the same. Therefore, the mechanism of the general decline in transduction efficiency in arthritic knee joints is probably related to the inflammatory cells in the synovial cavity, and/or to other changes in the synovium, like extracellular matrix changes. We have done a preliminary experiment to determine the clinical significance of the tropism modification (results not shown). We transduced synovial biopsies from RA patients in vitro. The transduction efficiency in RA synovium was higher for the RGD-modified vectors than for the conventional virus, luciferase production was around the detection limit for the conventional AdV and easily measurable with the RGDmodified vectors.
Improvement of viral vectors for gene therapeutic application of arthritic diseases can also be achieved in different ways than by tropism modification. Production of anti-arthritic mediators can be improved by the use of tailor-made promoters, designed to achieve a higher transgene production, limiting the production to moments that it is required, thereby avoiding possible side-effects of the anti-inflammatory mediator, and avoiding compensatory mechanisms. Our own studies with the C3-Tat/HIV system clearly show the potential of such a promoter. 25 A combination of this promoter system with the tropism modification will result in a very efficient viral delivery system. The AdV itself also has some drawbacks that limit the application in arthritic diseases. Other viral systems, for instance the adeno-associated viruses (AAV), could be necessary for application in the clinic. Fortunately, the tropism of the AAV can also be optimized. [26] [27] [28] The combination of RGD-mediated delivery, disease inducibility of the transgene and the long-term presence of the exogenous DNA achieved by the AAV would make an ideal vector system.
Introduction of a RGD motif in the capsid of the AdV significantly enhanced transduction efficiency of the synovial membrane, and this resulted in a significant improvement in the ability of the AdV to inhibit a murine arthritis model.
Materials and methods
Animals
Male DBA-1/bom mice were purchased from Bomholdgärd (Ry, Denmark). C57/Bl6 mice were bred at our animal facility. The mice were housed in filter-top cages. Adenoviral vector injected mice were kept in low-pressure isolators and used between 10 and 12 weeks of age. They were fed a standard diet and tap water ad libitum. All in vivo studies complied with national legislation and were approved by local authorities of the Care of Use of Animals with related codes of practice.
Adenoviral vectors and transduction
We used the first generation replication-deficient adenoviral vectors AdCMVLuc, 8 Ad5LucRGD, 8 Ad5GFP, Ad5GFPRGD, Ad5mIL-1Ra and Ad5mIL-1RaRGD. All viral vectors were made as has been described, 29 and are E1A,B and E3 deleted. In the Ad5LucRGD, Ad5GFPRGD and Ad5mIL-1RaRGD viruses, the Arg-Gly-Asp (RGD) amino acids were added to the H1 loop of the fiber knob, all RGD-modified viruses are isogenic compared with their control virus, except for the added RGD sequence. Particles were measured spectrophotometrically by the method of Mittereder et al. 30 To determine the titer of infectious viral particles, the vector stock was titrated on 911 indicator cells and viral capsid protein was detected 20 h after transduction by immunohistochemistry. 31 Infectious titers (ffu) and particle concentration (vp) per ml of the used viral stocks were: AdCMVLuc; 1.2 × 10 
Semi-quantitative reverse transcriptase PCR
Total RNA was extracted from a cell line that originates from the synovium of C57/BL6 mice (obtained from Dr P van Lent from our laboratory) or from synovial biopsies obtained from normal or arthritic murine knee joints. The isolated RNA was treated with DNAse-I (Life Technologies, Carlsbad, CA, USA) to remove possible contamination of the samples with genomic DNA. The isolated mRNA was reverse transcribed using oligo(dT) 15 primers (Eurogentic, Liège, Belgium). Amplification of cDNA was done up to 40 cycles. Estimation of mRNA levels was performed as has been described previously. 32 Five-microliter samples were taken at increasing cycle numbers at five-cycle intervals. The PCR products were electrophoresed in a 1.5% agarose gel containing ethidium bromide. The cycle number when the product was first detected was taken as a measure for the amount of specific mRNA. Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) mRNA levels were used as an internal control.
The primers used in the amplification reaction were the following. Primers specific for GAPDH had the sequence 5'-AACTCCCTCAAGATTGTCAGCA-3' and 5'-TCCAC CACCCTGTTGGCTGTA-3'. Primers specific for the ␣ v integrin subunit had the sequence 5'-ACACT TTGGGCTGTGGAATC-3' and 5'-CAGAGTTTCCTT CGCCATTC-3'. Primers specific for the mCAR had the sequence 5'-CCTGGGGTTGCAAATAAGAA-3' and 5'-TGCAGCTGTATGTCCCAGAA-3'.
Luciferase measurements
Patellae with surrounding tissue were dissected, put in 250 l cell culture lysis buffer (Promega, Madison, WI, USA) and snap frozen in liquid nitrogen. Samples were thawed, vortexed for 2 min, and centrifuged for 1 min at 13 000 r.p.m. We measured luciferase in 10 l of the supernatant with the luciferase assay system (Promega) according to the manufacturer's protocol in a luminometer (Polarstar Galaxy, BMG, Offenburg, Germany). Total protein concentration in the supernatant was determined with Coomassie protein assay reagent (Pierce, Rockford, IL, USA). The relative light units (RLU) of luciferase per mg total protein was calculated.
Detection of GFP in cryostate sections
One day after injection of the Ad5GFP or Ad5GFPRGD vector, knee joints were isolated and embedded tissuetek OCT compound (Sakura Finetek Europe BV, Zoeterwoude, The Netherlands) and snap frozen in liquid nitrogen. 10 m cryostat sections were made and sections were attached to adhesive tape, 33 and fixed in -20 o C methanol for 10 min. Sections were dried, counterstained with EtBr (10 g/ml in physiological salt), and mounted in a 7% gelatine/50% glycerol solution in water.
Murine IL-1RA ELISA To measure intra-articular mIL-1Ra production, patellae with surrounding synovium were isolated from knee joints in a standardized manner and incubated for 1 h in 200 l DMEM (GIBCO BRL, Breda, The Netherlands) supplemented with streptomycin and penicillin at room temperature. ELISA plates (Cliniplate; HB Lab Systems, Helsinki, Finland) were coated with the capture antibody (MAB480, R&D Systems, Minneapolis, USA; 3 g/ml in 0.1 m carbonate buffer (pH 9.6), overnight incubation at 4°C). Non-specific binding sites were blocked by a 1-h incubation with 1% BSA in PBS (pH 7.5). After washing, 100 l of the culture supernatants were added to the wells and incubated for 3 h at room temperature. The plates were then incubated with the biotin-labeled secondary antibody (BAF480, R&D Systems, 0.25 g/ml diluted in 0.1% BSA in PBS, pH 7.5) for 2 h, followed by a 30-min incubation with streptavidin-conjugated polyhorseradish peroxidase (0.25 g/ml) (Central Laboratory of Blood Transfusion, Amsterdam, The Netherlands).
Gene Therapy
Bound complexes were detected by incubation with the Supersignal ELISA femto chemiluminescent substrate (Pierce) and light output was measured in a luminometer (Polarstar Galaxy).
Zymosan-induced arthritis model
Zymosan-induced arthritis (ZIA) was induced by intraarticular injection of zymosan (yeast particles). 10 7 ffu of the adenoviral vectors were intra-articularly injected 4 weeks after ZIA induction.
Streptococcus cell wall model
Cell walls from Streptococcus pyogenes were prepared as has been described previously. 34 Unilateral arthritis was induced by intra-articular injection of 24 g SCW in 6 l PBS into the right knee joint of C57/Bl6 mice.
Collagen-induced arthritis model
Bovine type II collagen was prepared as has been described, 35 diluted in 0.05 m acetic acid to a concentration of 2 mg/ml and emulsified with an equal volume of CFA (2 mg/ml of Mycobacterium tuberculosis; strain H37Ra; Difco Laboratories, Detroit, MI, USA). The mice were immunized intradermally at the base of the tail with 100 l of emulsion (100 g bovine collagen type II). At day 22, mice were given an intraperitoneal booster injection of 100 g collagen type II dissolved in phosphate buffered saline (PBS). On day 24, AdV was injected into both knees of mice that had no clinical signs of arthritis. Arthritis development was then monitored macroscopically until day 38. Mice were considered to have arthritis when considerable changes in redness and/or swelling were noted in digits or other parts of the paws. At later time-points, ankylosis was also included in macroscopic scoring. Clinical severity was graded on a scale of 0 to 2 for each paw, according to changes in redness and swelling: 0, no changes; 0.25, 1-2 toes affected; 0.5, 3-5 toes; 0.5, ankle swelling; 0.5, footpad swelling; 0.5, severe overall swelling and ankylosis. Two independent observers, without knowledge of the experimental groups scored the clinical signs of arthritis in the paws.
For the therapeutic experiment, DBA/1 mice with at least one CIA-positive paw were selected on day 25 of the immunization protocol. On day 25 and 27, AdV were injected in both knee joints, and clinical signs of CIA in the paws was followed until day 32.
Histology
Whole knee joints were removed and fixed for 4 days in 10% formalin. After decalcification in 5% formic acid, the specimens were processed for paraffin embedding. 36 Tissue sections (7 m) were stained with safranin O. Histopathological changes were arbitrarily scored by two independent observers using the following parameters. Inflammation was scored on a scale of 0-3, depending upon the number of inflammatory cells in the synovial cavity (exudate) and synovial tissue (infiltrate). A characteristic parameter in CIA is the progressive loss of bone and non-calcified cartilage. This destruction was scored on a scale from 0 to 3, ranging from no damage to complete loss of bone structure or of the non-calcified cartilage layer. Glycosaminoglycan (GAG) depletion of the non-calcified cartilage layer was scored in safranin Ostained sections on a scale of 0 to 3, ranging from no loss to complete loss of staining or loss of the non-calcified cartilage layer.
Statistical analysis
Means ± s.e.m. of the various groups were determined and potential differences between the groups were tested with the Wilcoxon signed ranks test for all non-parametric data and the Students' t test for parametric data.
